Dr. Sarah Goldberg on Further Immunotherapy Trials in Non-Small Cell Lung Cancer
March 29th 2016Sarah Goldberg, MD, MPH, assistant professor of Medicine and Medical Oncology, Yale Cancer Center, discusses coming trials looking at immunotherapy beyond the second-line setting in non-small cell lung cancer (NSCLC).